2Brownlee M.Biochemistry and molecular cell biology of diabetic complications[J].Nature,2001,414(6865):813-20.
3MacCarthy PA,Grieve DJ, Li JM, et al. m paired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase[J]. Circulation, 2001,104:2967-2974.
4WARNHOLTZ A,NICKEING G, SCHULZ E, et al. Increased NADH-oxidase mediated superoxide production in the early stages of atherosclerosis[J]. Circulation, 1999,99( 15):2027-2033.
5O'DONNELL R W,JOHNSON D K,ZIEGLER L M,et al. Endotheial NADPH oxidas:mechanism of activation by low-density lipoprotion[J]. Endothelial Cell Res,2003,10(6):291-297.
6Zhao Q,Egashira K,Inoue S,et al.Vascular endothelial growth factor is n ecessary in the development of arteriosclerosis by recruiting/ activating m onocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation,2002,105 (9): 1110-1115.
7Makoto Katoh,Kensuke Egashira,Chu Kataoka,et al.Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats[J].Am J Physiol Heart Circ Physio1,2004,286(2):H768-H774.
8Davignon J.Beneficial cardiovascular pleiotropic effects of statins[J]. Circulati on,2004,109 (supplllI):39-43.
9Vecchione C,Brandes R P.Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.Circ Res,2002,91 (2): 173 -9.
10Wassmann S,LaufsU,Muller K, et al.Cellular antioxidant effects of atorvasta tin in vitro and in vivo.Arterioscler Thromb Vasc Biol,2002,22(2):300-305.
